Kewalramani Reshma

CEO &President | Director | EVP And CMO

2 companies

Average

Trades Analyzed

12M Win Rate

35.7%

Avg 3M Return

-1.1%

Avg 12M Return

-6.4%

Kewalramani Reshma is a Director at DNA with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 39 sells.

Estimated insider holdings value: $59.0M based on current market prices.

Holdings by Company

DNAJun 12, 2024

Current Shares186.0K

Value$1.66M

Net Activity0

Bought: 0Sold: 0

VRTXFeb 13, 2026

Current Shares133.5K

Value$57.38M

Net Activity-134,557

Bought: 20.0KSold: 154.6K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 27, 2023	VRTX Vertex Pharmaceuticals Inc / Ma	CEO &President	Sell	3,317	$339.08	$1,124,726.05	-0.9%	+3.7%	+17.1%
Jan 25, 2023	VRTX Vertex Pharmaceuticals Inc / Ma	CEO &President	Sell	10,000	$315.05	$3,150,500.00	-10.0%	+5.3%	+36.4%
Aug 15, 2022	VRTX Vertex Pharmaceuticals Inc / Ma	CEO &President	Sell	11,689	$305.06	$3,565,846.34	-10.5%	+0.2%	+14.5%
Jun 24, 2022	VRTX Vertex Pharmaceuticals Inc / Ma	CEO &President	Sell	11,689	$291.30	$3,405,005.70	-9.5%	-2.1%	+18.6%
Aug 19, 2021	VRTX Vertex Pharmaceuticals Inc / Ma	CEO &President	Buy	10,000	$195.65	$1,956,491.60	+7.5%	-3.5%	+53.3%
Aug 6, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	CEO &President	Sale+OE	2,073	$271.20	$562,204.97	-1.5%	-	-
May 15, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	CEO &President	Sell	99	$284.17	$28,132.46	-	-	-
May 6, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	CEO &President	Sale+OE	2,074	$272.85	$565,882.14	-1.5%	-	-
Feb 25, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP And CMO	Sell	3,634	$233.45	$848,371.19	-1.6%	-	-
Feb 18, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP And CMO	Sell	1,183	$243.51	$288,069.99	-0.7%	-	-